ÌÇÐÄÆƽâ°æ

As of March 1, 2022, Egypt administered a total of 71.36 million doses of the vaccine against the coronavirus (COVID-19). The country was the first African nation to receive doses, in December 2020, and started its vaccination campaign on January 24, 2021, as part of phase three clinical trials of the vaccine developed in China and produced by Sinopharm. On March 31, 2021, the country received its first batch of AstraZeneca/Oxford vaccine via the COVAX initiative. Moreover, Egypt domestically produces the Sinovac vaccine in Egypt in its state-owned vaccine production company and plans to further increase its production to become a hub for producing vaccines.